5 Firms Lead Trio Of Biotech IPOs Raising $721M Combined
Three biotechnology firms went public to receptive investors Friday after raising $721 million combined in initial public offerings guided by five law firms, led by an upsized offering by Recursion Pharmaceuticals...To view the full article, register now.
Already a subscriber? Click here to view full article